All In MedTech

FDA Clearance Tracker · P970051-S140

NUCLEUS COCHLEAR IMPLANT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 20, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 20, 2016

Approved

Time to decision

180 days

Received Dec 23, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P970051-S140
Device name
NUCLEUS COCHLEAR IMPLANT SYSTEM
Applicant location
Lone Tree, CO
Received
Dec 23, 2015
Decided
Jun 20, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P970051

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

Approval for the optional acoustic component amplifies low frequency sound, and sends it into the ear canal. The acoustic component is intended to provide access to these low frequency sounds for some Cochlear Nucleus implant recipients.The acoustic component is indicated for recipients of traditional Cochlear Nucleus implants with unaided air conduction thresholds less than or equal to 85 dB HL between 125 Hz and 2000 Hz following surgery. The acoustic component should only be used when behavioural audiometric thresholds can be obtained and the recipient can provide feedback regarding sound quality.Speech perception testing should be completed before and after fitting with the acoustic component to ensure that the recipient performs as well, if not better, with the acoustic component than without it.

Source documents

Other decisions for Cochlear Americas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.